QQ客服 官方微博 反馈留言

	Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
	Cui, Jinglin; Chen, Hong; Lu, Hang; Dong, Fangtian; Wei, Dongmei; Jiao, Yan; Charles, Steve; Gu, Weikuan; Wang, Lin
	2018
卷号	2018页码:4927259
ISSN号	2090-004X
DOI	10.1155/2018/4927259
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6356315
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Cui, Jinglin,Chen, Hong,Lu, Hang,et al. Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy[J],2018,2018:4927259.
APA	Cui, Jinglin.,Chen, Hong.,Lu, Hang.,Dong, Fangtian.,Wei, Dongmei.,...&Wang, Lin.(2018).Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy.,2018,4927259.
MLA	Cui, Jinglin,et al."Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy".2018(2018):4927259.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。